Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Mar 16, 2015
Insider Transaction Report
Form 4
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2015-03-12+8,297→ 8,297 totalExercise: $10.22Exp: 2025-03-11→ Common Stock (8,297 underlying)
Footnotes (1)
- [F1]This option vested as to 25% of the underlying shares on March 13, 2015 (the "Vesting Commencement Date") and vests as to an additional 25% of the underlying shares on each of the first, second and third anniversaries of the Vesting Commencement Date.